ESC 365 - Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus

Back

ESC Professional Premium Access

Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

Session: Drug-coated balloons, stents, and scaffolds

Topic: Restenosis

Speaker: Doctor A. Hanzek (Zagreb, HR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Antonio Hanzek

University Hospital Centre Zagreb, Zagreb (Croatia)

0 follower

5 more presentations in this session

Long term safety of paclitaxel coated balloon for de novo non-small coronary lesions

Speaker: Doctor X. He (Galway, IE)

Access

Abstract

Slides

Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels

Speaker: Doctor R. Bando (Tokushima, JP)

Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease intervention.

Speaker: Doctor V. Tsampasian (Norwich, GB)

Drug coated balloon treatment with or without long inflation time in patients undergoing percutaneous coronary intervention: a propensity score matching analysis

Speaker: Doctor Y. Fujiwara (Tenri, JP)

The impact of underlying plaque characteristics following the novel resorbable magnesium scaffold implantation: an intravascular OCT assessment up to 12-months

Speaker: Doctor A. Aytekin (Munich, DE)

Access the full session

Drug-coated balloons, stents, and scaffolds

Speakers: Doctor A. Hanzek, Doctor X. He, Doctor R. Bando, Doctor V. Tsampasian, Doctor Y. Fujiwara...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources